Picture courtesy The News Minute
New Delhi: Bharat Biotech-developed vaccine candidate COVAXIN will be affective on mutant strains of the novel coronavirus, the company expressed confidence at a press conference on Monday.
According to Bharat Biotech chairman and managing director, Dr Krishna Ella, the company will be able to establish the “hypothesis” of the candidate’s ability to protect against mutations in a week.
“It’s only a hypothesis right now…but just give me one week’s time (and) I’ll give confirmatory data,” Dr Ella was quoted as saying by The Indian Express.
He was responding to a query on whether there were data to show Covaxin is effective against the mutant strain of the SARS-CoV-2 virus. The second strain was first detected in the United Kingdom and has since been found in over 30 other countries.
ALSO READ: Covaxin 200% Safe, Says Bharat Biotech MD After Backlash On Vaccine Efficacy
Mumbai: Bollywood celebrities have often had funny, at times bizarre experiences, mostly involving hero-worshipping, demanding fans.…
Bhubaneswar: Police have arrested the owner of a Jatra (theatre) group for allegedly duping an…
Sanskriti Talwar Faridkot (Punjab): For the third consecutive year, Balwinder Singh of Mallan village in…
Bhubaneswar: Rain may play spoilsport in Christmas and New Year celebrations in Odisha as the…
New Delhi: Netflix showed the way, Amazon Prime Video is following in their footsteps. Come…
Hyderabad: Allu Arjun’s woes keep mounting. In a worrying development, protesters stormed Allu Arjun’s Jubilee…
This website uses cookies.